INFERIOR VENA CAVAL OCCLUSION side effect
What is INFERIOR VENA CAVAL OCCLUSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INFERIOR VENA CAVAL OCCLUSION and Recently Reported Side Effects
INFERIOR VENA CAVAL OCCLUSION and 15 most Active Side Effect polls
INFERIOR VENA CAVAL OCCLUSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Citalopram Side Effects Report #5576071-6
Physician from UNITED KINGDOM reported CITALOPRAM HYDROBROMIDE problem on Dec 12, 2007. Male patient, 49 years of age, weighting 183.0 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ALENDRONIC ACID, PROCHLORPERAZINE. Patient recovered.
Citalopram Side Effects Report #5510177-2
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from UNITED KINGDOM on Oct 22, 2007. Male patient, 49 years of age, weighting 183.0 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, MIRTAZAPINE, PROCHLORPERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Citalopram Side Effects Report #5491430-8
Health Professional from UNITED KINGDOM reported CITALOPRAM HYDROBROMIDE problem on Oct 09, 2007. Male patient, 49 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ALENDRONIC ACID, PROCHLORPERAZINE. Patient recovered.
Citalopram Side Effects Report #5494885-8
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2007. Male patient, 49 years of age, weighting 183.0 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, MIRTAZAPINE, PROCHLORPERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Citalopram Side Effects Report #5497109-0
Health Professional from UNITED KINGDOM reported CITALOPRAM problem on Oct 08, 2007. Male patient, 49 years of age, was diagnosed with depression and was treated with CITALOPRAM. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, MIRTAZAPINE, PROCHLORPERAZINE, MALEATE. Patient was hospitalized. Patient recovered.
Citalopram Side Effects Report #5500073-9
CITALOPRAM HYDROBROMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2007. Female patient, 49 years of age, was diagnosed with ovarian cancer and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, ureteric obstruction, . CITALOPRAM HYDROBROMIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Citalopram Side Effects Report #5500075-2
Consumer or non-health professional from UNITED KINGDOM reported CITALOPRAM HYDROBROMIDE problem on Oct 09, 2007. Male patient, 49 years of age, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, MIRTAZAPINE, PROCHLOPRERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Citalopram Side Effects Report #5500245-3
CITALOPRAM HYDROBROMIDE problem was reported by a Health Professional from UNITED KINGDOM on Oct 10, 2007. Male patient, 49 years of age, weighting 183.0 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, retroperitoneal fibrosis, . CITALOPRAM HYDROBROMIDE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, MIRTAZAPINE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.
Ortho Side Effects Report #5403180-4
Consumer or non-health professional from UNITED STATES reported ORTHO EVRA problem on Nov 29, 2006. Female patient, 31 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, . ORTHO EVRA dosage: unknown. Patient was hospitalized. Patient recovered.
Ortho Side Effects Report #5403180-4
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Female patient, 31 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: inferior vena caval occlusion, . ORTHO EVRA dosage: unknown. Patient was hospitalized. Patient recovered.
Thalomid Side Effects Report #5695451-1
Consumer or non-health professional from UNITED STATES reported THALOMID problem on Mar 26, 2008. Male patient, 73 years of age, was diagnosed with cytogenetic analysis abnormal, multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: constipation, fatigue, inferior vena caval occlusion, intestinal obstruction, no therapeutic response, pyrexia, . THALOMID dosage: 100 MG, 1 IN 1 D, ORAL; 100 MG-200MG, DAILY, ORAL. During the same period patient was treated with NEUPOGEN, PROCRIT, DECADRON. Patient was hospitalized. Patient recovered.
Sirolimus Side Effects Report #5317081-3
SIROLIMUS problem was reported by a Physician from NETHERLANDS on Apr 30, 2007. Male patient, weighting 165.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, impaired healing, inferior vena caval occlusion, proteinuria, pulmonary embolism, removal of renal transplant, renal haemorrhage, wound infection, . SIROLIMUS dosage: LOADING DOSE OF 15 MG. During the same period patient was treated with METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, DACLIZUMAB. Patient was hospitalized and became disabled. Patient recovered.